Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sankyo prepares ACAT inhibitors

March 26, 1997

Bone-selective estrogen derivatives claimed by Sumitomo

March 25, 1997

Yakult Honsha discloses ACAT inhibitors

March 25, 1997

New drug therapy for erectile dysfunction more effective than PGE1

March 24, 1997

Lilly to discontinue or alter rHb1.1 collaboration with Somatogen

March 21, 1997

FDA clears Skelid

March 21, 1997

Amylin and J&J broaden collaboration

March 20, 1997

Collaboration formed to identify chronic anemia treatment

March 20, 1997

Phase II trial of Leukine as adjuvant for advanced melanoma

March 20, 1997

Grelan characterizes candidate for diabetic complications

March 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...